Cephalon

TRUXIMA

  1. Home
  2.  / 
  3. Q Code
  4.  / TRUXIMA – Q5115

Manufacturer:

Cephalon

Name:

TRUXIMA

HCPCS Code Descriptor:

Injection, rituximab-abbs, biosimilar, (truxima), 10 mg

Category:

Q Code

HCPCS:

Q5115

NDC(s):

63459-0103-10, 63459-0104-50

Primary Type:

Oncology Biosimilar

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

TRUXIMA is an Oncology Biosimilar drug manufactured by Cephalon and administered via the Intravenous route of administration. The Q Code: Q5115 is aligned to the drug TRUXIMA.

Truxima is used to treat certain types of cancer, joint pain, certain blood vessel diseases, and a certain skin condition. Truxima works by slowing down or stopping the growth of certain cells, which can be cancer-causing. Truxima is a branded drug manufactured by Cephalon and is a biosimilar to the reference product Rituxan (J9312). Patient assistance programs for this medication can be found through Teva pharmaceuticals.

Access Pricing and More By Registering

HCPCS Added Date:

7/1/19

HCPCS Effective Date:

7/1/19

HCPCS Short Description:

Inj truxima 10 mg

Billing and Coding Guide:

Not Found

Patient Assistance:

https://www.truximahcp.com/support-resources